Walker LSK - Search Results

1

Study of an extended family with CTLA-4 deficiency suggests a CD28/CTLA-4 independent mechanism responsible for differences in disease manifestations and severity.

Hou TZ, Olbrich P, Soto JML, Sanchez B, Moreno PS, Borte S, Stauss HJ, Burns SO, Walker LSK, Pan-Hammarström Q, Hammarström L, Sansom DM, Neth O. Hou TZ, et al. Among authors: walker lsk. Clin Immunol. 2018 Mar;188:94-102. doi: 10.1016/j.clim.2018.01.001. Epub 2018 Jan 3. Clin Immunol. 2018. PMID: 29305966 Free article.

2

Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells.

Boshell M, McLeod J, Walker L, Hall N, Patel Y, Sansom D. Boshell M, et al. Immunology. 1996 Apr;87(4):586-92. doi: 10.1046/j.1365-2567.1996.509582.x. Immunology. 1996. PMID: 8675213 Free PMC article.

3

Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95.

McLeod JD, Walker LS, Patel YI, Boulougouris G, Sansom DM. McLeod JD, et al. J Immunol. 1998 Mar 1;160(5):2072-9. J Immunol. 1998. PMID: 9498743

4

Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis.

Walker LS, McLeod JD, Boulougouris G, Patel YI, Hall ND, Sansom DM. Walker LS, et al. Immunology. 1998 May;94(1):41-7. doi: 10.1046/j.1365-2567.1998.00490.x. Immunology. 1998. PMID: 9708185 Free PMC article.

5

Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.

Boulougouris G, McLeod JD, Patel YI, Ellwood CN, Walker LS, Sansom DM. Boulougouris G, et al. J Immunol. 1998 Oct 15;161(8):3919-24. J Immunol. 1998. PMID: 9780158

6

IL-2-independent activation and proliferation in human T cells induced by CD28.

Boulougouris G, McLeod JD, Patel YI, Ellwood CN, Walker LS, Sansom DM. Boulougouris G, et al. J Immunol. 1999 Aug 15;163(4):1809-16. J Immunol. 1999. PMID: 10438913

7

Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.

Walker LS, McLeod JD, Boulougouris G, Patel YI, Ellwood CN, Hall ND, Sansom DM. Walker LS, et al. Immunology. 1999 Dec;98(4):569-75. doi: 10.1046/j.1365-2567.1999.00925.x. Immunology. 1999. PMID: 10594690 Free PMC article.

8

CTLA4 gene polymorphism and autoimmunity.

Gough SC, Walker LS, Sansom DM. Gough SC, et al. Immunol Rev. 2005 Apr;204:102-15. doi: 10.1111/j.0105-2896.2005.00249.x. Immunol Rev. 2005. PMID: 15790353 Review.

9

The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology.

Sansom DM, Walker LS. Sansom DM, et al. Immunol Rev. 2006 Aug;212:131-48. doi: 10.1111/j.0105-2896.2006.00419.x. Immunol Rev. 2006. PMID: 16903911 Review.

10

Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21.

Clough LE, Wang CJ, Schmidt EM, Booth G, Hou TZ, Ryan GA, Walker LS. Clough LE, et al. J Immunol. 2008 Apr 15;180(8):5393-401. doi: 10.4049/jimmunol.180.8.5393. J Immunol. 2008. PMID: 18390721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page